• Personal Stories

Brave women stand up to cancer and bare their mastectomy scars

Powerful images have been released as part of the Stand Up To Cancer campaign and the project coincides with Breast Cancer Awareness Month this October. Powerful images have been released as part of the Stand Up To Cancer campaign and the project coincides with Breast Cancer Awareness Month this October.

2 October 2017

• Health & Medicine

Breast cancer drug not recommended for use in England

The drug fulvestrant (Faslodex) has not been recommended in England to treat late stage breast cancer, in draft guidance. The drug fulvestrant (Faslodex) has not been recommended in England to treat late stage breast cancer, in draft guidance.

1 September 2017

• Health & Medicine

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care. A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

31 August 2017

• Health & Medicine

Targeted radiotherapy limits side effects of breast cancer treatment

Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment. Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment.

2 August 2017

• Science & Technology

Stem cell treatment kills cancer cells that have spread in mice

A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study. A new stem cell-based cancer treatment can target and kill breast cancer cells that have spread in mice, according to a new study.

27 July 2017

• Science & Technology
• Health & Medicine

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer. A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

20 June 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer. The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

16 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Alcohol and breast cancer – how big is the risk?

A new report on breast cancer risk has made the headlines - but what does the evidence say? A new report on breast cancer risk has made the headlines - but what does the evidence say?

25 May 2017